News
Brescia, Italy February 28, 2020 – With the surging demand for sample collection kits for diagnosing COVID-19 and other upper respiratory tract pathogens, COPAN is concentrating its efforts on strategic items to maximize product output and supply during the ongoing…
Read More
On January 30th, 2020, the World Health Organization (WHO) held its second meeting in Geneva of the International Health Regulations Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). During the meeting the committee agreed that the outbreak constitutes a…
Read More
Fecal specimens have been utilized in the microbiology laboratory for years in order to detect bacterial gastrointestinal (GI) pathogens by culture. More recently, molecular assays have been developed to detect not only bacterial GI pathogens, but viral and parasitic causes…
Read More
COPAN continues to innovate and is leading the field of Artificial Intelligence (A.I.) and digital culture plate reading in clinical Microbiology. A groundbreaking study titled “Automated Detection of Streptococcus pyogenes pharyngitis using COLOREX Strep A CHROMagar and WASPLab™ Artificial Intelligence Chromogenic Detection Module Software” was recently published on the Journal of Clinical Microbiology (JCM). The study is the first-in-its class peer-reviewed publication on PhenoMATRIX™ used with COLOREX Strep A culture media for the automatic detection of Group A Strep (GAS).
Read More
COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIX™ for Detection of Group A Streptococcus Using CHROMagar’s COLOREX™ Media
Read More
COPAN Announces FecalSwab® Stool Collection and Transport Device Certified Free of Nucleic Acids
Read MoreCOPAN is focused on the industry standard quality of its innovative products and remains actively committed to protecting its intellectual property rights globally, including the patent infringement and unfair competition lawsuit that COPAN filed in U.S. federal district court last year.
Read MoreMaine’s highest court, the Maine Supreme Judicial Court, affirmed a summary judgment entered in favor of Copan Italia S.p.A. and against Puritan Medical Products Company, LLC on Puritan’s state law claim for bad faith assertion of patent infringement.
Read More
COPAN Announces the Worldwide Launch of CYCLONE AUTO-PREP™ with Smart Incubators and AI for Automatic Determination of Bacterial Growth During the Upcoming International Association for Food Protection (IAFP) Annual Meeting
Read MoreCOPAN Italia S.p.A. and its U.S. subsidiary, COPAN Diagnostics Inc. announced today that they have filed a lawsuit against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC, in the United States District Court for the District of Maine for infringement of U.S. Patent No. 8,114,027, U.S. Patent No. 8,317,728, U.S. Patent No. 8,979,784, U.S. Patent No. 9,011,358, and U.S. Patent No. 9,173,779.
Read More